Yangling Keyspharma Co. Limited, established in 2011, has expanded a compositive entity from initially only as a small laboratory. The company dedicated to the development, production and marketing of chemicals. Main products Roflumilast (CAS: 162401-32-3); Roflumilast InterMediate (CAS: 162401-62-9); Hydroxytyrosol (CAS: 10597-60-1); Sclareolide(CAS: 564-20-5); -Ambroxide(CAS: 6790-58-5).
Keyspharma focus on:
-Organic compounds
-Active Pharmaceutical Ingredient(s)
-Nutritional products
-Custom synthesis
-Contract Manufacturing